Yersinia Infections

Download PDF

Recent Publications on Yersinia Infections:
Crosstalk of signalling processes of innate immunity with Yersinia Yop effector functions. The interaction of microbial pathogens with host cells critically...	10th July, 2008	Institute for Medical Microbiology, Virology and Hygiene, University	Immunobiology. 2008;213(3-4):261-9. Epub 2007 Dec 31. DOI Direct Link
Biochemical functions of Yersinia type III effectors. Yersinia uses a type III secretion system (TTSS) to deliver six effector...	28th May, 2008	National Institute of Biological Sciences, Zhongguancun Life Science Park,	Curr Opin Microbiol. 2008 Feb;11(1):21-9. Epub 2008 Mar 4. DOI Direct Link
Resistance of chemokine receptor 6-deficient mice to Yersinia enterocolitica infection: evidence of defective M-cell formation in vivo. M cells, specialized cells within Peyer's patches (PPs), are reduced in...	10th May, 2008	Department of Medicine B, University of Muenster, Albert-Schweitzer	Am J Pathol. 2008 Mar;172(3):671-80. Epub 2008 Feb 7. DOI Direct Link
A Csr-type regulatory system, including small non-coding RNAs, regulates the global virulence regulator RovA of Yersinia pseudotuberculosis through RovM. The MarR-type regulator RovA controls expression of virulence genes of...	24th April, 2008	Institut fur Mikrobiologie, Technische Universitat Braunschweig, 38106	Mol Microbiol. 2008 Jun;68(5):1179-95. Epub 2008 Apr 22. DOI Direct Link
Bath vaccination of rainbow trout (Oncorhynchus mykiss Walbaum) against Yersinia ruckeri: effects of temperature on protection and gene expression. Protection of rainbow trout fry following bath vaccination with a bacterin...	11th April, 2008	Faculty of Life Sciences, Department of Veterinary Pathobiology,	Vaccine. 2008 Feb 20;26(8):1050-62. Epub 2008 Jan 10. DOI Direct Link
→View more research publications.

Yersinia Infections Clinical Trials:
Treatment and Diagnosis of Plague	Plague Interventions: Drug: gentamicin;   Drug: streptomycin
Clinical Studies of Kikuchi's Disease	Lymphadenitis Intervention: Procedure: blood sampling, neck lymph node biopsy
One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)	Plague Interventions: Biological: Alhydrogel;   Biological: rF1 and rV protein antigens
Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V	Pneumonic Plague;   Preventive Therapy

Yersinia Infections Patents:
US Patent No.	Title
7001718	Method of inhibiting pathogenicity of infectious agents
6706522	Plasmid DNA from Yersinia pestis
6054133	Anti-microbial targeting for intracellular pathogens
5985285	Vaccines for plague

BioPortfolio Ltd. offers e-mail and postal lists for Yersinia Infections scientists - we have details of around 273 individuals working on Yersinia Infections .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.